Valneva (VALN)
(Delayed Data from NSDQ)
$8.69 USD
+0.49 (5.92%)
Updated May 22, 2024 10:51 AM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 42% (144 out of 249)Zacks Sector Rank
Top 44% (7 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.40 | 1.69 | 9.99 |
Current Quarter Estimate | -0.39 | 5.88 | 57.00 |
Year Ago Quarter Estimate | -0.26 | 4.88 | 52.54 |
Next Quarter Estimate | -0.39 | 7.06 | 61.00 |
Next Year Estimate | -0.95 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 53.50 | 14.90 | 15.67 |
Next Year | -30.14 | 19.90 | 9.31 |
Last 5 Years | NA | 3.90 | 8.10 |
Next 5 Years | NA | 12.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -13.85 |
Price/Book (MRQ) | 2.78 | 2.18 |
Price/Cash Flow (MRFY) | NA | 11.64 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -15.88% | -10.23% |
Return on Equity (TTM) | -14.56% | -3.83% |
Debt to Equity (MRQ) | 0.84 | 20.61 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.